Results 81 to 90 of about 55,599 (265)

Measuring intra-industry trade and productivity in the South African pharmaceutical sector

South African Journal of Economic and Management Sciences
Background: The South African pharmaceutical sector is Africa’s largest and most advanced but heavily depends on imported products and active pharmaceutical ingredients to meet its demands.
Nwabisa Malimba, Tsitsi E. Mutambara, Juniours Marire   +2 more
doaj   +1 more source

RP-HPLC Analysis of and Chemical Changes during Fermentation

Natural Product Communications, 2010
Jirakadyarishta , an Ayurvedic formulation prepared by the fermentation of a decoction of Cuminum cyminum (seeds) is traditionally used for intestinal disorders. RP-HPLC analysis of the decoction and the final processed formulation revealed that apigenin-
Uma Ranjan Lal, Shailendra Mani Tripathi, Sanjay M. Jachak, Kamlesh Kumar Bhutani, Inder Pal Singh   +4 more
doaj   +1 more source

R&D in the Belgian Pharmaceutical Sector [PDF]

SSRN Electronic Journal, 2006
The Belgian pharmaceutical sector has been accorded a leading role in the attainment of the R&D investment targets which the EU Member States set themselves as part of the Lisbon strategy. To gain a better insight into that sector’s research activities, the NBB conducted an ad hoc survey in 2005, covering pharmaceutical companies active in Belgium in ...
openaire   +3 more sources

In Situ Contact Angle Measurement for Autonomous Spin Coating in Self‐Driving Labs

Advanced Intelligent Discovery, EarlyView.
A vision‐based add‐on transforms commercial spin coaters into autonomous modules of Self‐Driving Labs. Combining a width‐scaled U‐Net with classical geometric analysis, the system simultaneously measures contact angles and estimates substrate pose using a single camera.
Sven Fischer, Micha Hiegle, Holger Röhm
wiley   +1 more source

Transparency in public pharmaceutical sector: the key informants' perceptions from a developing country. [PDF]

BMC Health Serv Res, 2021
Esfandiari A, Yazdi-Feyzabadi V, Zarei L, Rashidian A, Salari H.   +4 more
europepmc   +1 more source

Pharmaceutical sector in Yemen

Janaki Medical College Journal of Medical Science, 2017
Not available.Janaki Medical College Journal of Medical Sciences (2016) Vol.
openaire   +2 more sources

Integrating Reinforcement Learning With Explainable Artificial Intelligence for Real‐Time Clinical Decision Support in Dynamic Healthcare Environments

Advanced Intelligent Systems, EarlyView.
A hybrid Reinforcement Learning–Explainable AI framework integrates SHAP and LIME explanations directly into a Deep Q‐Network inference loop for real‐time ICU decision support. Trained on 18 142 mechanically ventilated stays from the eICU database, the system attains 93.0% decision accuracy, 20% fewer errors than RL alone, and a 91% clinician trust ...
Jannatul Ferdaus Disha, MD Faiaz Zaman Dehan, Kazi Md. Tanvir Anzum   +2 more
wiley   +1 more source

Exploring Corporate Capital Structure and Overleveraging in the Pharmaceutical Industry

Risks
This paper applies an empirical model of corporate capital structure, optimal debt, and overleveraging to estimate overleveraging measured as the difference between actual and optimal debt.
Samar Issa, Hussein Issa
doaj   +1 more source

Essential, Yet Precarious, Mistreated, Sick and Medicalized: A Sequential Explanatory Mixed‐Methods Study on Homecare Aides in Spain

American Journal of Industrial Medicine, EarlyView.
ABSTRACT Background Homecare aides (HCAs) are professional non‐family caregivers, who support dependent individuals to live at home with dignity; yet in Spain they remain understudied and vulnerable, often facing precarious working conditions. We aimed to characterize HCAs’ employment, living conditions, health, and exposure to workplace violence and ...
Albert Navarro‐Giné, Pedro Ferrer‐Rosende, Maria Feijoo‐Cid, Sergio Salas‐Nicás, Laura Esteve‐Matalí, Valeria Stuardo‐Ávila, María Isabel Fernández‐Cano   +6 more
wiley   +1 more source

Policies and measures implemented to reduce the impact of international sanctions on Iran's pharmaceutical sector. [PDF]

Res Pharm Sci, 2022
Emami F, Cheraghali AM.
europepmc   +1 more source